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schemia Syndrome Evaluation (WISE) Study
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OBJECTIVES We investigated the relationship between coronary vascular reactivity and functional capacity
as assessed from the Duke Activity Status Index (DASI) in a cohort of women evaluated for
suspected ischemia.
BACKGROUND Reduced functional capacity and impaired vascular reactivity are associated with poor
prognosis, but an association between vascular reactivity and functional capacity is unknown.
METHODS A total of 190 women enrolled in the National Heart, Lung, and Blood Institute
(NHLBI)-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study had baseline
clinical assessment and coronary artery flow velocity response to adenosine (CFVRado). We
compared these results with self-reported DASI metabolic equivalents (METs).
RESULTS Mean age was 55  11 years (range 21 to 83 years), and only 18% had coronary stenosis
50%. Women with a CFVRado 2.5 (n  98) had mean DASI of 15.1  13.6, compared
to women (n  92) with CFVRado 2.5, whose mean DASI was 21.0  15.2 (p  0.004).
This relationship was maintained after adjusting for age and presence of coronary artery
disease. CFVRado of 2.5 was associated with a DASI of 20 (odds ratio 3.03, 95%
confidence interval 1.56 to 5.90, p  0.001).
CONCLUSIONS Women with reduced CFVRado were significantly more likely to have reduced functional
capacity. Impairment in coronary vascular function and reduced levels of activity may both
play a role in the poorer prognosis observed in the WISE study women; however, the
relationship between the two is still unclear. (J Am Coll Cardiol 2006;47:44S–9S) © 2006
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.023by the American College of Cardiology Foundation
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cxercise capacity is among the most important predictors of
ardiovascular adverse outcomes in healthy men (1) and
omen (2) as well as in those with coronary artery disease
CAD) (3). The factors contributing to impaired exercise
apacity appear multifactoral and include increasing age, sed-
ntary lifestyle, depression, obesity, and other comorbidities as
ell as impaired cardiovascular function. Recent research has
uggested similar correlations between exercise capacity and
ortality in asymptomatic women, independent of other
ardiovascular risk factors (2,4). The mechanisms to explain
his relationship are not clear. In addition to traditional exercise
esting, the Duke Activity Status Index (DASI) is a well
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L64914-01, and UO1-HL65924-01.e
Manuscript received September 28, 2004; revised manuscript received January 11,
005, accepted January 17, 2005.alidated measure of functional capacity that can be expressed
s metabolic equivalents (METs) and has been shown to
orrelate with adverse outcomes (5–7). In the National Heart,
ung, and Blood Institute (NHLBI)-sponsored Women’s
schemia Syndrome Evaluation (WISE) study, women evalu-
ted for suspected ischemia all had assessments of functional
apacity, including DASI scores, and a subgroup also had
ssessments of coronary vascular reactivity. Previous analyses of
his relatively healthy group of women have demonstrated that
oth lower DASI scores and impaired large coronary artery
ndothelial function are associated with adverse cardiovascular
utcomes (8,9). In this work, we investigated the relationship
f DASI score to vascular reactivity assessed from coronary
ow response to adenosine (CFVRado) in these women.
ETHODS
tudy population. The WISE study is an NHLBI-
ponsored four-center study that aims to improve diagnostic
esting in the evaluation of ischemic heart disease in women.
total of 936 women with chest pain (mean age 5812
ears; range 21 to 86 years), presenting for clinically indi-
ated angiograms to evaluate suspected myocardial isch-
mia, were enrolled from 1996 to 2000. The institutional
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February 7, 2006:44S–9S Coronary Vascular Reactivity in Womeneview board at each site approved the study, participant
onsent was obtained at enrollment, and all data were
onitored by an independent data and safety monitoring
ommittee. Major exclusion criteria were comorbidity that
ould compromise follow-up, pregnancy, contraindications
o provocative diagnostic testing, cardiomyopathy, severe
ongestive heart failure, recent myocardial infarction, sig-
ificant valvular or congenital heart disease, and a language
arrier to questionnaire testing. Full details of the protocol
nd design of the WISE study have been previously pub-
ished (10). The present study population consisted of the
90 WISE study participants who had measurements of
oronary vascular function with adenosine.
aseline evaluation. Baseline evaluation consisted of a
hysical exam and collection of clinical data, including the
ASI questionnaire. Demographic, clinical, and angio-
raphic data were collected at the WISE study data coor-
inating center in Pittsburgh, Pennsylvania. Qualitative and
uantitative coronary angiographic analyses were carried out
y a core laboratory (Rhode Island Hospital, Providence,
hode Island) according to methodology and definitions
reviously published from the WISE study (11). We de-
ned any angiographic stenosis of 50% of luminal diam-
ter as significant CAD. The CAD severity score was
erived as an aggregate of percentage of luminal stenosis,
xtent and location of stenosis, and degree of collateral
essels (11).
easurement of functional capacity. The DASI is a score
erived from a 12-item self-reported questionnaire that
aptures a person’s ability to perform various routine activ-
ties. These activities have been shown to accurately esti-
ate peak oxygen consumption (5,6). By dividing the DASI
core by 3.5, MET levels were derived. Women with a
ASI score of 20, which corresponds to 5.7 METs, were
onsidered functionally impaired (12).
easurement of coronary microvascular function. To
ssess coronary vascular function, testing was performed in
left coronary artery branch (left anterior descending
oronary artery [n  137] or circumflex coronary artery [n
53]) without obstructive atherosclerosis (diameter steno-
is 50%) after vasoactive medications had been withdrawn
or at least 48 h. To assess blood flow velocity reserve, a
oppler-tipped guidewire (0.014-inch FloWire; Jomed/
ardiometrics, Mountain View, California) was advanced
Abbreviations and Acronyms
CAD  coronary artery disease
CFVRado  coronary flow velocity response to adenosine
CI  confidence interval
DASI  Duke Activity Status Index
METs  metabolic equivalents
NHLBI  National Heart, Lung, and Blood Institute
WISE  Women’s Ischemia Syndrome Evaluationhrough the diagnostic catheter, and recordings were made snce a stable Doppler signal in the proximal or mid vessel
as obtained. Intracoronary bolus injections of 18 g
denosine (Adenocard; Fujisawa USA, Deerfield, Illinois)
ere administered into the left main coronary artery. The
oronary flow velocity increase resulting from dilation of the
icrovasculature was measured (11). A CFVRado of 2.5
as taken to represent impaired coronary vascular function.
13).
tatistical analysis. The primary analysis in this report is
he relationship between functional capacity as assessed by
ASI scores and a measure of coronary reactivity using
FVRado. The relationships among these measurements
nd other demographic and CAD risk factor variables were
lso investigated. For comparing women with normal
CFVRado2.5) versus impaired (CFVRado2.5) coronary
eactivity, and normal (DASI 20) versus impaired (DASI
20) functional capacity, unadjusted means  standard
eviations or frequencies (%) were calculated. We also used
ertile analysis to examine the gradient between high,
edium, and low CFVRado and high, medium, and low
ASI in this study population. The Mantel-Haenszel chi
quare was used to evaluate the p value for trend. Because
emographic and/or clinical data tend to have skewed
istributions, we used Wilcoxon rank sum tests to compare
ontinuous variables, chi square tests to compare categorical
ariables, and Spearman rank correlations to describe the
elationship between continuous variables. Logistic regres-
ion analysis was used to adjust these for age and CAD.
tepwise logistic regression analysis was used to model
ormal versus low functional capacity as a function of
oronary reactivity and other coronary risk factors. Variables
onsidered for inclusion in the model included the baseline
haracteristics listed in Tables 1 and 2, and variables were
hen chosen for entry into multivariable models based upon
nivariate associations of p  0.10. In order to account for
ossible modulator effects, we then forced all other variables
rom Tables 1 and 2 into the models, one at a time.
ummary statistics for the regression models included the
-statistic (a measure of association of predicted probabilities
nd observed prevalence of a binary outcome) and R2
re-scaled for use in logistic regression). For all analyses, a
wo-tailed p value of 0.05 was considered statistically
ignificant.
ESULTS
aseline characteristics of the women are shown in Table 1.
n general, these 190 women in the coronary vascular
unction substudy population are very similar to the total
ISE study cohort (10). The mean age was 55  11 years
nd 18% were nonwhite minorities, primarily African
merican. Three-quarters were postmenopausal, and about
alf were obese (body mass index 30 kg/m2) and had
ypertension or dyslipidemia. Seventy percent of the WISE
tudy women had a family member with premature heart
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Coronary Vascular Reactivity in Women February 7, 2006:44S–9Sisease. Twenty percent had a history of diabetes mellitus,
urrently smoked, or had significant angiographic CAD.
omewhat more than half of the women had an impaired
FVRado (2.5). This population was also characterized by
mpaired functional capacity, with a mean DASI of 18.0 
4.6 (equivalent to 5.1 METS), and two-thirds having a
ASI of 20. Only 10% indicated that they could partic-
pate without difficulty in strenuous sports, which included
wimming (question 12 in the DASI). Women with im-
aired CFVRado were significantly older, had higher systolic
lood pressure, pulse pressure, and beta-blocker use, and
ore frequently had impaired functional capacity. No other
aboratory values or medication use were significantly dif-
erent. The differences between women with normal and
mpaired CFVRado persisted even after adjusting for age and
resence of CAD (Table 1).
Baseline characteristics of the women categorized by
mpaired versus normal functional capacity (DASI 20 vs.
20) are summarized in Table 2. The group with impaired
unctional capacity had significantly lower CFVRado com-
ared to the group with normal functional capacity (2.4 
.7 vs. 2.7  0.7; p  0.004). Women with impaired
unctional capacity also had significantly higher CAD se-
able 1. Characteristics of Women With Coronary Flow Velocit
Overall
(n  190)
ge (yrs) 55  11
ostmenopausal (%) 75
onwhite race (%) 18
MI (kg/m2) 31.2  7.3
aist-hip ratio 0.88  0.13
aist circumference 38.1  7.5
ystolic BP (mm Hg) 135  20
iastolic BP (mm Hg) 77  10
ulse pressure (mm Hg) 58  17
istory of hypertension (%) 56
istory of dyslipidemia (%) 51
iabetes (%) 21
emoglobin 13.0  1.4
amily history of CAD (%) 70
ast smoker (%) 57
urrent smoker (%) 20
AD 50% stenosis (%) 18
AD severity score 8.6  6.2
ASI 18.0  14.6
ASI 20 (%) 66
edication use
Current HRT (%) 44
Ever used HRT (%) 54
Beta-blockers (%) 29
Statins (%) 17
ACE inhibitors (%) 25
Aspirin (%) 49
Calcium antagonists (%) 27
Nitrates (%) 19
p  0.05 after adjusting for age and presence of significant CAD.
ACE  angiotensin-converting enzyme; BMI  body mass index; BP  blood
denosine; DASI  Duke Activity Status Index; HRT  hormone replacement theerity scores, and a higher proportion had significant CAD o24% vs. 8%; p  0.007). Use of aspirin, calcium antago-
ists, and nitrates was seen in significantly higher percent-
ges of women with impaired functional capacity compared
o those with normal functional capacity. After adjusting for
ge and presence of CAD, only normal CFVRado (p 
.01), and nitrate use (p  0.01) remained significantly
redictive. The presence and severity of CAD also remained
ignificant after adjustment for age.
The Spearman rank correlation between DASI and
FVRado was 0.20 (p  0.005). Figure 1 characterizes the
omen by tertiles for both DASI and CFVRado. For each
ncreasing tertile of CFVR, a higher proportion of women
ad normal functional capacity and a decreasing proportion
f women had low functional capacity (p for trend  0.02).
Independent predictors of normal versus reduced func-
ional capacity are summarized in Table 3. When modeled
sing a stepwise regression and adjusting for baseline
ifferences, the best independent predictors of normal
unctional capacity were: CFVRado 2.5 (odds ratio [OR]
.03, 95% confidence interval [CI] 1.56 to 5.90; p 0.001),
AD severity score (OR 0.92, 95% CI 0.85 to 0.99; p 
.04), and diastolic blood pressure (OR 1.03, 95% CI 1.001
o 1.07; p  0.04) (Table 3). Substituting presence/absence
erve Assessments
ado <2.5
 98)
CFVRado >2.5
(n  92)
Unadjusted
p Value
 12 53  9 0.01*
77 72 0.40
13 23 0.08
 6.3 31.3  8.3 0.52
 0.14 0.87  0.13 0.03
 7.3 37.6  7.8 0.31
 21 131  17 0.007*
 9 76  11 0.56
 19 55  14 0.009*
61 50 0.12
57 44 0.08
26 16 0.12
 1.5 13.0  1.3 0.68
70 70 0.98
58 56 0.82
17 23 0.34
23 14 0.13
 7.2 7.7  4.8 0.09
 13.6 21.0  15.2 0.004*
78 54 0.0007*
39 49 0.14
49 60 0.16
38 20 0.006*
20 13 0.18
28 22 0.35
54 44 0.19
26 28 0.79
20 18 0.74
re; CAD  coronary artery disease; CFVRado  coronary flow velocity response toy Res
CFVR
(n
56
31.1
0.89
38.6
139
77
62
13.0
9.4
15.1f obstructive CAD did not greatly affect the model,
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February 7, 2006:44S–9S Coronary Vascular Reactivity in Womenlthough nitrate use entered as a significant covariate.
imilarly, limiting the analysis to only those without CAD
id not change the model. To exclude the modulating effect
f other variables, we added each variable from Tables 1 and
in turn to the models. These were not independent
redictors of functional capacity, nor did their addition to
he model affect the robust relationship between CFVRado
nd DASI.
able 2. Characteristics of Women by Assessment of Functional
DASI <20
(n  126)
ge (yrs) 54  11
ostmenopausal (%) 76
onwhite race (%) 18
MI (kg/m2) 31.4  7.4
ystolic BP (mm Hg) 135  20
iastolic BP (mm Hg) 76  10
ulse pressure (mm Hg) 59  17
istory of hypertension (%) 59
istory of dyslipidemia (%) 56
iabetes (%) 24
amily history of CAD (%) 70
urrent smoker (%) 23
AD 50% stenosis (%) 24
AD severity score 9.4  6.6
FVRado 2.4  0.7
FVRado 2.5 (%) 40
edication use
Current HRT (%) 44
Ever used HRT (%) 55
Beta-blockers (%) 32
Statins (%) 18
ACE inhibitors (%) 25
Aspirin (%) 56
Calcium blockers (%) 32
Nitrates (%) 25
bbreviations as in Table 1.
igure 1. Percentage of women with low, medium, and high Duke
ctivity Status Index (DASI) by coronary flow velocity (CFR). DASI
ertiles: 0 to 9.8 (n  63), 9.9 to 19.9 (n  63), 20 to 58.2 (n  62).
FVRado tertiles: 0.58 to 2.22 (n  63), 2.23 to 2.69 (n  65), 2.7 to 4.48t
n  62). Open bars  low DASI; solid bars  medium DASI; ruled
ars  high DASI.ISCUSSION
ur results suggest a significant relationship between im-
aired coronary flow reserve and overall functional capacity
n women with suspected ischemic heart disease. In previous
tudies, DASI has been shown to be a reliable and valid
ssessment of functional capacity as expressed in METs (5).
he observed relationship between DASI and coronary flow
eserve was independent of age and CAD and offers one
ossible link to explain the resulting impairment in func-
ional capacity observed in these women. The mechanism
esponsible for the observed impairment of coronary vascu-
ar function on the overall functional capacity is unknown.
Exercise capacity has been shown to be an important
rognostic predictor in patients with cardiovascular disease.
n a study involving more than 6,000 men who underwent
linically indicated exercise electrocardiogram treadmill, a
ow metabolic equivalent was associated with mortality (1).
eak exercise capacity measured by METs was the strongest
redictor of death in patients with cardiovascular disease
nd also in normal subjects (14). Exercise capacity was a
tronger predictor of mortality than traditional risk factors
or cardiovascular disease. Furthermore, in patients with
eart failure, decreased functional capacity has been shown
o be associated with worse cardiovascular outcomes (15). In
ddition to the high-risk patient groups, impaired exercise
apacity has been shown to correlate with cardiovascular
eath in asymptomatic men (1). In a recent analysis from
city
I >20
 64)
p Value
(Unadjusted)
p Value (Adjusted for
Age and CAD)
 10 0.75 0.28
73 0.66 0.36
19 0.83 0.42
 7.3 0.51 0.85
 19 0.61 0.95
 10 0.21 0.10
 17 0.32 0.28
50 0.25 0.28
41 0.08 0.20
16 0.19 0.44
69 0.83 0.89
14 0.14 0.20
8 0.007 0.006
 5.0 0.002 0.01
 0.7 0.004 0.01
66 0.0007 0.001
44 0.97 0.92
54 0.92 0.76
22 0.12 0.18
14 0.46 0.54
25 0.46 0.54
38 0.02 0.08
19 0.06 0.08
8 0.004 0.01Capa
DAS
(n
55
30.9
136
78
57
6.9
2.7he Women Take Heart project, exercise capacity was found
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Coronary Vascular Reactivity in Women February 7, 2006:44S–9So be a strong independent predictor of all-cause death in
symptomatic women as well (2). This relationship held
ven after adjusting for traditional cardiac risk factors. For
ach MET increase in exercise capacity, a 17% reduction in
ortality rate was seen. More recent WISE study data have
hown that lower functional capacity, assessed by DASI,
as associated with higher prevalence of coronary heart
isease risk factors and angiographic CAD at baseline and
ssociated with higher risk of adverse events during inter-
ediate follow-up and was independent of both traditional
ardiovascular risk factors and anthropometric measure-
ents (9).
The exact mechanisms responsible for this observed
elationship are unclear. In our study, impaired overall
unctional capacity was independently associated with cor-
nary microvascular dysfunction. Impaired vascular function
s believed to be integral to the formation of atherosclerotic
eart disease. The identification of endothelial dysfunction
n the absence of significant occlusive disease presents a
lobal pattern of dysfunction in the macro- and microcir-
ulation and has been postulated to represent one of the
arliest manifestations of atherosclerosis (16). Impaired
ascular function has been shown to be independently
ssociated with adverse cardiovascular outcomes in the
bsence of epicardial coronary disease (17). This is the first
tudy to demonstrate that non–endothelial-dependent mi-
rovascular dysfunction is associated with decreased func-
ional capacity in women. Decreased functional capacity in
he WISE study women has been recently shown to be
orrelated with adverse outcome (9). Disordered vascular
mooth muscle and endothelial interactions may contribute
o the ability of the coronary vessels to respond to changes
n perfusion pressure and metabolic demands during isch-
mia and infarction. This and other nonatherosclerotic
echanisms could contribute to the decreased functional
apacity and poor outcomes observed in women with
able 3. Independent Predictors of Normal Versus Reduced Fun
Predictor
. Model obtained by stepwise regression (c-statistic  0.72; R2  0.16)
CFVRado 2.5
CAD severity score
Diastolic BP
. Model obtained when not entering CAD severity score (c-statistic  0
CFVRado 2.5
CAD 50% stenosis
Nitroglycerin use
. Model obtained by stepwise regression for women without CAD only
(c-statistic  0.67; R2  0.13)
CFVRado 2.5
Nitroglycerin use
he following variables were entered into the logistic model were not independent c
ulse pressure, history of dyslipidemia, and use of beta-blockers, aspirin, calcium blo
t a time, but their inclusion did not affect the relationship between CFVR 2.5 a
ypertension or diabetes, hemoglobin, family history of CAD, current or ever smokin
nzyme inhibitors.
CAD  coronary artery disease; CFVRado  coronary flow velocity response toschemic heart disease. oInterventions targeting decreased functional capacity have
esulted in improvements in both symptoms and measures
f microvascular function. Eriksson et al. (18) compared an
ight-week exercise training program to a control group in
atients with syndrome X. The exercise training resulted in
significant increase in exercise capacity with less anginal
ain. There was a trend toward an endothelium-dependent
lood flow increases after training (p  0.06). Recent work
y Woo et al. (19) suggests improvements in arterial
ndothelial function after six weeks to one year of diet versus
iet and exercise in a group of 82 obese but otherwise
ealthy children. At one year, there was significantly less
arotid intimal thickening in the group that continued to
iet and exercise and sustained improvement in arterial
ndothelial function. Data from Hambrecht et al. (20) have
emonstrated that impairment in coronary artery endothe-
ial function could be reversed by a short-term moderate
evel of exercise training. Our data, which demonstrates that
ncreasing levels of functional capacity are associated with
ncreases in CFVRado, would support the hypothesis that
f vascular dysfunction is reversible, an intervention that
ncreases functional capacity should increase vascular func-
ion. Hambrecht et al. (20) also observed that exercise
raining resulted in improvements in agonist-mediated
ndothelium-dependent vasodilatory capacity of the left
nternal mammary artery in patients with CAD. There was
significant increase in endothelial nitric oxide synthase
rotein expression in the training group compared with the
ontrol group. We have observed that hemoglobin levels
how an association with DASI scores, vascular reactivity,
nd adverse cardiovascular outcomes in the WISE study
opulation (21). Thus we could postulate a possible inter-
ction among nitric oxide metabolism, hemoglobin levels,
nd impaired microvascular function (22), which all ulti-
ately may contribute to reduced functional capacity and
orsened cardiovascular outcome. This interaction also
al Capacity (DASI 20 vs. 20)
Odds Ratio 95% CI p Value
3.03 1.56–5.90 0.001
0.92 0.85–0.99 0.04
1.03 1.001–1.07 0.04
2  0.18)
2.76 1.44–5.30 0.002
0.34 0.12–0.95 0.04
0.26 0.10–0.74 0.01
154)
3.02 1.51–6.04 0.002
0.33 0.11–0.94 0.04
tes: age, race, waist-hip ratio, systolic blood pressure, diastolic blood pressure (BP),
or nitrates. The above and the following variables were forced into the models one
SI 20: postmenopausal status, body mass index, waist circumference, history of
ent or ever hormone replacement therapy, and use of statins, angiotensin-converting
ine; CI  confidence interval; DASI  Duke Activity Status Index.ction
.69; R
(n 
ovaria
ckers,
nd DA
g, currpens another possible therapeutic target for future studies.
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February 7, 2006:44S–9S Coronary Vascular Reactivity in WomenThe American Heart Association has expressed the need
o find noninvasive screening tests that predict cardiac risk
23). In women, the need for better risk stratification is
xtremely important, given the gender-related diagnostic
ilemmas. Because, as shown here, lower DASI scores
orrelate with impaired coronary vascular function and
lsewhere with higher risk for adverse outcomes, the DASI
ay be a simple and easy to use tool that contributes to the
lobal risk assessment. This instrument is easy to use and
heap and needs further study to confirm our findings.
tudy limitations. Our study evaluated a relatively small
roup of women with chest pain and ischemic-type symp-
oms warranting referral for coronary angiography, which
ay lead to a referral bias and limited generalization of the
esults. We measured coronary vascular response at only one
oint in time, so unknown or unmeasurable factors could
otentially alter the responses at that point in time. Our
ross-sectional design precludes inferring a causal relation-
hip between vascular reactivity and functional capacity.
onclusions. Women with reduced CFVRado were signif-
cantly more likely to have reduced functional capacity as
ssessed by the DASI. The DASI may offer a simple
oninvasive measure of global cardiovascular risk that is
inked to impairment in coronary vascular function.
eprint requests and correspondence: Dr. Eileen Handberg,
ivision of Cardiovascular Medicine, University of Florida Col-
ege of Medicine, P.O. Box 100277, Gainesville, Florida 32610-
277. E-mail: handbem@medicine.ufl.edu.
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